Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solu...